Common pathological processes in Alzheimer disease and type 2 diabetes: A review

A synaptic model of memory: long-term potentiation in the hippocampus

Bliss, T. V. P., & Collingridge, G. L. (1993) · Nature · doi:10.1038/361031a0 · Cited by 11,566 · see citing works

Biochemistry and molecular cell biology of diabetic complications

Brownlee, M. (2001) · Nature · doi:10.1038/414813a · Cited by 9,107 · see citing works

Alzheimer's Disease: Genes, Proteins, and Therapy

Selkoe, D. J. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.741 · Cited by 6,063 · see citing works

Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein

Glenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(84)80190-4 · Cited by 5,404 · see citing works

Alzheimer’s disease

Blennow, K., de Leon, M. J., & Zetterberg, H. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69113-7 · Cited by 3,134 · see citing works

Transforming Growth Factor β in Tissue Fibrosis

Epstein, F. H., Border, W. A., & Noble, N. A. (1994) · New England Journal of Medicine · doi:10.1056/nejm199411103311907 · Cited by 3,067 · see citing works

Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease

Shull, M. M., Ormsby, I., Kier, A. B., Pawlowski, S., Diebold, R. J., Yin, M., Allen, R., Sidman, C., Proetzel, G., Calvin, D., et al. (1992) · Nature · doi:10.1038/359693a0 · Cited by 2,985 · see citing works

Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels

Saxena, R., Voight, B. F., Lyssenko, V., Burtt, N. P., de Bakker, P. I. W., Chen, H., Roix, J. J., Kathiresan, S., Hirschhorn, J. N., Daly, M. J., et al. (2007) · Science · doi:10.1126/science.1142358 · Cited by 2,843 · see citing works

Advanced glycation end-products: A review

Singh, R., Barden, A., Mori, T., & Beilin, L. (2001) · Diabetologia · doi:10.1007/s001250051591 · Cited by 2,597 · see citing works

Replication of Genome-Wide Association Signals in UK Samples Reveals Risk Loci for Type 2 Diabetes

Zeggini, E., Weedon, M. N., Lindgren, C. M., Frayling, T. M., Elliott, K. S., Lango, H., Timpson, N. J., Perry, J. R. B., Rayner, N. W., Freathy, R. M., et al. (2007) · Science · doi:10.1126/science.1142364 · Cited by 2,194 · see citing works

Diabetes mellitus and the risk of dementia: The Rotterdam Study

Ott, A., Stolk, R. P., van Harskamp, F., Pols, H. A. P., Hofman, A., & Breteler, M. M. B. (1999) · Neurology · doi:10.1212/wnl.53.9.1937 · Cited by 2,175 · see citing works

GSK-3: tricks of the trade for a multi-tasking kinase

Doble, B. W., & Woodgett, J. R. (2003) · Journal of Cell Science · doi:10.1242/jcs.00384 · Cited by 2,084 · see citing works

Neurotrophic and Neurotoxic Effects of Amyloid β Protein: Reversal by Tachykinin Neuropeptides

Yankner, B. A., Duffy, L. K., & Kirschner, D. A. (1990) · Science · doi:10.1126/science.2218531 · Cited by 1,975 · see citing works

Controlling TGF-beta signaling.

Massagué, J., & Chen, Y. (2000) · PubMed · Cited by 1,780 · see citing works

Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease – is this type 3 diabetes?

Steen, E., Terry, B. M., J. Rivera, E., Cannon, J. L., Neely, T. R., Tavares, R., Xu, X. J., Wands, J. R., & de la Monte, S. M. (2005) · Journal of Alzheimer's Disease · doi:10.3233/jad-2005-7107 · Cited by 1,703 · see citing works

Glycosylation and the Immune System

Rudd, P. M., Elliott, T., Cresswell, P., Wilson, I. A., & Dwek, R. A. (2001) · Science · doi:10.1126/science.291.5512.2370 · Cited by 1,588 · see citing works

Controlling TGF-β signalingPreprint

Massagué, J., & Chen, Y. (2000) · Genes & Development · doi:10.1101/gad.14.6.627 · Cited by 1,571 · see citing works

Negative regulation of transforming growth factor-β by the proteoglycan decorin

Yamaguchi, Y., Mann, D. M., & Ruoslahti, E. (1990) · Nature · doi:10.1038/346281a0 · Cited by 1,516 · see citing works

Uber eine eigenartige Erkrankung der Hirnrinde

Alzheimer, A. (1907) · Medical Entomology and Zoology · Cited by 1,503 · see citing works

An english translation of alzheimer’s 1907 paper, “über eine eigenartige erkankung der hirnrinde”

Stelzmann, R. A., Norman Schnitzlein, H., & Reed Murtagh, F. (1995) · Clinical Anatomy · doi:10.1002/ca.980080612 · Cited by 1,455 · see citing works

Cycling of O-linked β-N-acetylglucosamine on nucleocytoplasmic proteins

Hart, G. W., Housley, M. P., & Slawson, C. (2007) · Nature · doi:10.1038/nature05815 · Cited by 1,418 · see citing works

Insulin-degrading enzyme regulates the levels of insulin, amyloid β-protein, and the β-amyloid precursor protein intracellular domain in vivo

Farris, W., Mansourian, S., Chang, Y., Lindsley, L., Eckman, E., Frosch, M., Eckman, C., Tanzi, R., Selkoe, D., & Guénette, S. (2003) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.0230450100 · Cited by 1,361 · see citing works

Sniffing neuropeptides: A transnasal approach to the human brain

Born, J., Lange, T., Kern, W., McGregor, G. P., Bickel, U., & Fehm, H. L. (2002) · Nature Neuroscience · doi:10.1038/nn0602-849 · Cited by 1,356 · see citing works

Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients.

Cooper, G. J., Willis, A. C., Clark, A., Turner, R. C., Sim, R. B., & Reid, K. B. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.23.8628 · Cited by 1,299 · see citing works

Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function

Arvanitakis, Z., Wilson, R. S., Bienias, J. L., Evans, D. A., & Bennett, D. A. (2004) · Archives of Neurology · doi:10.1001/archneur.61.5.661 · Cited by 1,258 · see citing works

Deciphering the Molecular Basis of Memory Failure in Alzheimer's Disease

Walsh, D. M., & Selkoe, D. J. (2004) · Neuron · doi:10.1016/j.neuron.2004.09.010 · Cited by 1,207 · see citing works

Type 2 Diabetes, APOE Gene, and the Risk for Dementia and Related Pathologies

Peila, R., Rodriguez, B. L., & Launer, L. J. (2002) · Diabetes · doi:10.2337/diabetes.51.4.1256 · Cited by 1,207 · see citing works

GSK-3α regulates production of Alzheimer's disease amyloid-β peptides

Phiel, C. J., Wilson, C., Lee, V. M. ‐., & Klein, P. S. (2003) · Nature · doi:10.1038/nature01640 · Cited by 1,200 · see citing works

Insulin receptors are widely distributed in the central nervous system of the rat

Havránková, J., Roth, J., & Brownstein, M. (1978) · Nature · doi:10.1038/272827a0 · Cited by 1,116 · see citing works

A variant in CDKAL1 influences insulin response and risk of type 2 diabetes

Steinthorsdottir, V., Thorleifsson, G., Reynisdottir, I., Benediktsson, R., Jonsdottir, T., Walters, G. B., Styrkarsdottir, U., Gretarsdottir, S., Emilsson, V., Ghosh, S., et al. (2007) · Nature Genetics · doi:10.1038/ng2043 · Cited by 1,072 · see citing works

Alzheimer's disease-affected brain: Presence of oligomeric Aβ ligands (ADDLs) suggests a molecular basis for reversible memory loss

Gong, Y., Chang, L., Viola, K. L., Lacor, P. N., Lambert, M. P., Finch, C. E., Krafft, G. A., & Klein, W. L. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1834302100 · Cited by 1,061 · see citing works

Discovery of a metabolic pathway mediating glucose-induced desensitization of the glucose transport system. Role of hexosamine biosynthesis in the induction of insulin resistance.

Marshall, S., Bacote, V., & Traxinger, R. R. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)67706-9 · Cited by 1,049 · see citing works

Cholesterol, lipid rafts, and disease

Simons, K., & Ehehalt, R. (2002) · Journal of Clinical Investigation · doi:10.1172/jci16390 · Cited by 995 · see citing works

Increased Risk of Type 2 Diabetes in Alzheimer Disease

Janson, J., Laedtke, T., Parisi, J. E., O’Brien, P., Petersen, R. C., & Butler, P. C. (2004) · Diabetes · doi:10.2337/diabetes.53.2.474 · Cited by 950 · see citing works

Cholesterol, lipid rafts, and disease

Simons, K., & Ehehalt, R. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0216390 · Cited by 916 · see citing works

Neurotoxicity of a Fragment of the Amyloid Precursor Associated with Alzheimer's Disease

Yankner, B. A., Dawes, L. R., Fisher, S., Villa-Komaroff, L., Oster-Granite, M. L., & Neve, R. L. (1989) · Science · doi:10.1126/science.2474201 · Cited by 907 · see citing works

Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-β antibody in db/db diabetic mice

Ziyadeh, F. N., Hoffman, B. B., Han, D. C., de la Cruz, M. D. C. I., Hong, S. W., Isono, M., Chen, S., McGowan, T., & Sharma, K. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.120055097 · Cited by 907 · see citing works

Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus

Lorenzo, A., Razzaboni, B. L., Weir, G. C., & Yankner, B. A. (1994) · Nature · doi:10.1038/368756a0 · Cited by 819 · see citing works

Type 1 T regulatory cells

Roncarolo, M. G., Bacchetta, R., Bordignon, C., Narula, S. K., & Levings, M. K. (2001) · Immunological Reviews · doi:10.1034/j.1600-065x.2001.1820105.x · Cited by 814 · see citing works

Aggregation of vascular risk factors and risk of incident Alzheimer disease

Luchsinger, J. A., Reitz, C., Honig, L. S., Tang, M. X., Shea, S., & Mayeux, R. (2005) · Neurology · doi:10.1212/01.wnl.0000172914.08967.dc · Cited by 790 · see citing works

Cognition and synaptic plasticity in diabetes mellitus

Gispen, W. H., & Biessels, G. J. (2000) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01656-8 · Cited by 772 · see citing works

Brain insulin and insulin receptors in aging and sporadic Alzheimer’s disease

Frölich, L., Blum-Degen, D., Bernstein, H.-G., Engelsberger, S., Humrich, J., Laufer, S., Muschner, D., Thalheimer, A., Türk, A., Hoyer, S., et al. (1998) · Journal of Neural Transmission · doi:10.1007/s007020050068 · Cited by 748 · see citing works

Risk of Dementia among Persons with Diabetes Mellitus: A Population-based Cohort Study

Leibson, C. L., Rocca, W. A., Hanson, V. A., Cha, R., Kokmen, E., O'Brien, P. C., & Palumbo, P. J. (1997) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009106 · Cited by 700 · see citing works

Structure‐Activity Analyses of β‐Amyloid Peptides: Contributions of the β25–35 Region to Aggregation and Neurotoxicity

Pike, C. J., Walencewicz‐Wasserman, A. J., Kosmoski, J., Cribbs, D. H., Glabe, C. G., & Cotman, C. W. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.64010253.x · Cited by 699 · see citing works

The Importance of -Cell Failure in the Development and Progression of Type 2 Diabetes

Kahn, S. E. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.9.7713 · Cited by 694 · see citing works

Hyperinsulinemia and risk of Alzheimer disease

Luchsinger, J. A., Tang, M.-X., Shea, S., & Mayeux, R. (2004) · Neurology · doi:10.1212/01.wnl.0000140292.04932.87 · Cited by 683 · see citing works

β-Amyloid protein increases the vulnerability of cultured cortical neurons to excitotoxic damage

Koh, J., Yang, L. L., & Cotman, C. W. (1990) · Brain Research · doi:10.1016/0006-8993(90)91355-k · Cited by 617 · see citing works

Identification of insulin in rat brain.

Havránková, J., Schmechel, D. E., Roth, J., & Brownstein, M. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.11.5737 · Cited by 607 · see citing works

TGF-β1 promotes microglial amyloid-β clearance and reduces plaque burden in transgenic mice

Wyss-Coray, T., Lin, C., Yan, F., Yu, G.-Q., Rohde, M., McConlogue, L., Masliah, E., & Mucke, L. (2001) · Nature Medicine · doi:10.1038/87945 · Cited by 587 · see citing works

Islet Amyloid: A Critical Entity in the Pathogenesis of Type 2 Diabetes

Hull, R. L., Westermark, G. T., Westermark, P., & Kahn, S. E. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0405 · Cited by 580 · see citing works

Common mechanisms of amyloid oligomer pathogenesis in degenerative disease

Glabe, C. G. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.04.017 · Cited by 569 · see citing works

Dynamic O-GlcNAc Modification of Nucleocytoplasmic Proteins in Response to Stress

Zachara, N. E., O'Donnell, N., Cheung, W. D., Mercer, J. J., Marth, J. D., & Hart, G. W. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403773200 · Cited by 568 · see citing works

Distinct molecular mechanisms and divergent endocytotic pathways of AMPA receptor internalization

Lin, J., Ju, W. H., Foster, K. A., Lee, S. H., Ahmadian, G., Wyszynski, M. W., Wang, Y. T., & Sheng, M. (2000) · Nature Neuroscience · doi:10.1038/81814 · Cited by 557 · see citing works

Kinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degeneration

Wang, J., Grundke, I., & Iqbal, K. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.05226.x · Cited by 553 · see citing works

Review of insulin and insulin-like growth factor expression, signaling, and malfunction in the central nervous system: Relevance to Alzheimer's disease

de la Monte, S. M., & Wands, J. R. (2005) · Journal of Alzheimer s Disease · doi:10.3233/jad-2005-7106 · Cited by 552 · see citing works

Insulin, insulin-degrading enzyme and amyloid-β peptide in Alzheimer's disease: review and hypothesis

Qiu, W. Q., & Folstein, M. F. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.01.004 · Cited by 538 · see citing works

Recruitment of functional GABAA receptors to postsynaptic domains by insulin

Wan, Q., Xiong, Z., Man, H., Ackerley, C., Braunton, J., Lu, W. Y., Becker, L. E., MacDonald, J. F., & Wang, Y. T. (1997) · Nature · doi:10.1038/41792 · Cited by 537 · see citing works

Longitudinal PET evaluation of cerebral metabolic decline in dementia: a potential outcome measure in Alzheimer’s disease treatment studies

Alexander, G. E., Chen, K., Pietrini, P., Rapoport, S. I., & Reiman, E. M. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.5.738 · Cited by 532 · see citing works

An in vivo model for the neurodegenerative effects of beta amyloid and protection by substance P.

Kowall, N. W., Beal, M. F., Busciglio, J. A., Duffy, L. K., & Yankner, B. A. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.16.7247 · Cited by 525 · see citing works

Intracerebroventricular administration of streptozotocin causes long-term diminutions in learning and memory abilities and in cerebral energy metabolism in adult rats.

Lannert, H., & Hoyer, S. (1998) · Behavioral Neuroscience · doi:10.1037/0735-7044.112.5.1199 · Cited by 525 · see citing works

Refining the impact of TCF7L2 gene variants on type 2 diabetes and adaptive evolution

Helgason, A., Pálsson, S., Þorleifsson, G., Grant, S. F. A., Emilsson, V., Gunnarsdottir, S., Adeyemo, A., Chen, Y., Chen, G., Reynisdóttir, I., et al. (2007) · Nature Genetics · doi:10.1038/ng1960 · Cited by 520 · see citing works

Evidence for Genetic Linkage of Alzheimer's Disease to Chromosome 10q

Bertram, L., Blacker, D., Mullin, K., Keeney, D. B., Jones, J., Basu, S., Yhu, S., McInnis, M. G., Go, R. C. P., Vekrellis, K., et al. (2000) · Science · doi:10.1126/science.290.5500.2302 · Cited by 519 · see citing works

Islet amyloid, increased A-cells, reduced B-cells and exocrine fibrosis: quantitative changes in the pancreas in type 2 diabetes.

Clark, A., Wells, C. A., BULEY, I. D., Cruickshank, J. K., Vanhegan, R. I., Matthews, D. R., Cooper, G. J. S., Holman, R. R., & Turner, R. C. (1988) · PubMed · Cited by 518 · see citing works

Insulin and the insulin receptor in experimental models of learning and memory

Zhao, W., Chen, H., Quon, M. J., & Alkon, D. L. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.02.045 · Cited by 503 · see citing works

Islet amyloid and type 2 diabetes mellitus.

Höppener, J., Bo, A.-R., & Lips, C. J. M. (2000) · New England Journal of Medicine · doi:10.1056/nejm200008103430607 · Cited by 499 · see citing works

Stimulation of β-Amyloid Precursor Protein Trafficking by Insulin Reduces Intraneuronal β-Amyloid and Requires Mitogen-Activated Protein Kinase Signaling

Gasparini, L., Gouras, G. K., Wang, R., Gross, R. S., Beal, M. F., Greengard, P., & Xu, H. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-08-02561.2001 · Cited by 493 · see citing works

Insulin receptors and insulin action in the brain: review and clinical implications

Schulingkamp, R. J., Pagano, T. C., Hung, D., & Raffa, R. B. (2000) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(00)00040-3 · Cited by 491 · see citing works

The source of cerebral insulin

Banks, W. A. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.02.040 · Cited by 489 · see citing works

The Role of Transforming Growth Factor β in Lung Development and Disease

Bartram, U., & Speer, C. P. (2004) · CHEST Journal · doi:10.1378/chest.125.2.754 · Cited by 489 · see citing works

Insulin Receptor Substrate-2 Deficiency Impairs Brain Growth and Promotes Tau Phosphorylation

Schubert, M., Brazil, D. P., Burks, D. J., Kushner, J. A., Ye, J., Flint, C. L., Farhang-Fallah, J., Dikkes, P., Warot, X. M., Rio, C., et al. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-18-07084.2003 · Cited by 488 · see citing works

Islet amyloid: a long-recognized but underappreciated pathological feature of type 2 diabetes.

Kahn, S. E., Andrikopoulos, S., & Verchere, C. B. (1999) · Diabetes · doi:10.2337/diabetes.48.2.241 · Cited by 488 · see citing works

Elevated nucleocytoplasmic glycosylation by O-GlcNAc results in insulin resistance associated with defects in Akt activation in 3T3-L1 adipocytes

Vosseller, K., Wells, L., Lane, M. D., & Hart, G. W. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.072072399 · Cited by 485 · see citing works

Anti-Inflammatory Drug Therapy Alters β-Amyloid Processing and Deposition in an Animal Model of Alzheimer's Disease

Yan, Q., Zhang, J., Liu, H., Babu-Khan, S., Vassar, R., Biere, A. L., Citron, M., & Landreth, G. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-20-07504.2003 · Cited by 469 · see citing works

Intracerebral streptozotocin model of type 3 diabetes: Relevance to sporadic Alzheimer’s disease

Lester-Coll, N., Rivera, E. J., Soscia, S. J., Doiron, K., Wands, J. R., & de la Monte, S. M. (2006) · Journal of Alzheimer s Disease · doi:10.3233/jad-2006-9102 · Cited by 467 · see citing works

The Hexosamine Signaling Pathway: Deciphering the "O-GlcNAc Code"

Love, D. C., & Hanover, J. A. (2005) · Science s STKE · doi:10.1126/stke.3122005re13 · Cited by 462 · see citing works

Ageing and diabetes: implications for brain function

Biessels, G. J., van der Heide, L. P., Kamal, A., Bleys, R. L. A. W., & Gispen, W. H. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)01486-3 · Cited by 458 · see citing works

Serum insulin-like growth factor I regulates brain amyloid-β levels

Carro, E., Trejo, J. L., Gómez‐Isla, T., LeRoith, D., & Torres‐Alemán, I. (2002) · Nature Medicine · doi:10.1038/nm793 · Cited by 448 · see citing works

Serum insulin-like growth factor I regulates brain amyloid-β levels

Carro, E., Jl, T., Gómez‐Isla, T., LeRoith, D., & Torres‐Alemán, I. (2002) · Nature Medicine · doi:10.1038/nm1202-793 · Cited by 442 · see citing works

Neuritic plaques and cerebrovascular amyloid in Alzheimer disease are antigenically related.

Wong, C. W., Quaranta, V., & Glenner, G. G. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.24.8729 · Cited by 438 · see citing works

Glucose metabolism and insulin receptor signal transduction in Alzheimer disease

Hoyer, S. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.02.049 · Cited by 436 · see citing works

O-GlcNAc Modification Is an Endogenous Inhibitor of the Proteasome

Zhang, F., Su, K., Yang, X., Bowe, D. B., Paterson, A. J., & Kudlow, J. E. (2003) · Cell · doi:10.1016/s0092-8674(03)00974-7 · Cited by 432 · see citing works

Ogt-Dependent X-Chromosome-Linked Protein Glycosylation Is a Requisite Modification in Somatic Cell Function and Embryo Viability

O'Donnell, N., Zachara, N. E., Hart, G. W., & Marth, J. D. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.4.1680-1690.2004 · Cited by 431 · see citing works

Latent transforming growth factor-beta in serum. A specific complex with alpha 2-macroglobulin.

O'Connor‐McCourt, M. D., & Wakefield, L. M. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47909-4 · Cited by 425 · see citing works

Diabetes mellitus and risk of dementia in the Kungsholmen project

Xu, W., Qiu, C., Wåhlin, Å., Winblad, B. G., & Fratiglioni, L. (2004) · Neurology · doi:10.1212/01.wnl.0000140291.86406.d1 · Cited by 409 · see citing works

Advanced Glycation End Products in Alzheimer's Disease and Other Neurodegenerative Diseases

Sasaki, N., Fukatsu, R., Tsuzuki, K., Hayashi, Y., Yoshida, T., Fujii, N., Koike, T., WAKAYAMA, I., Yanagihara, R. T., Garruto, R. M., et al. (1998) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65659-3 · Cited by 409 · see citing works

Glycogen synthase kinase 3: a drug target for CNS therapies

Bhat, R. V., Haeberlein, S. L. B., & Ávila, J. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02422.x · Cited by 408 · see citing works

Nitric oxide, the enigmatic neuronal messenger: its role in synaptic plasticity

Hölscher, C. (1997) · Trends in Neurosciences · doi:10.1016/s0166-2236(97)01065-5 · Cited by 408 · see citing works

Alzheimer's disease and Aβ toxicity: from top to bottom

Small, D. H., Mok, S. S., & Bornstein, J. C. (2001) · Nature reviews. Neuroscience · doi:10.1038/35086072 · Cited by 390 · see citing works

Brain insulin system dysfunction in streptozotocin intracerebroventricularly treated rats generates hyperphosphorylated tau protein

Grünblatt, E., Šalković‐Petrišić, M., Barilar, J. O., Riederer, P. F., & Hoyer, S. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04368.x · Cited by 376 · see citing works

The role of oxidative stress in the toxicity induced by amyloid β-peptide in Alzheimer’s disease

Miranda, S., Opazo, C., Larrondo, L. F., Muñoz, F. J., Ruiz, F., Leighton, F., & Inestrosa, N. C. (2000) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00015-0 · Cited by 369 · see citing works

The Microtubule-associated Protein Tau Is Extensively Modified with O-linked N-acetylglucosamine

Arnold, C. S., Johnson, G. W., Cole, R. N., Dong, D. L.-Y., Lee, M., & Hart, G. W. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.46.28741 · Cited by 361 · see citing works

Deficiency in neuronal TGF-β signaling promotes neurodegeneration and Alzheimer’s pathology

Tesseur, I., Zou, K., Esposito, L., Bard, F., Berber, E., Can, J. V., Lin, A. H., Crews, L., Tremblay, P., Mathews, P., et al. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27341 · Cited by 355 · see citing works

Pathogenesis of Age-Related Glucose Intolerance in Man: Insulin Resistance and Decreased β-Cell Function*

CHEN, M., BERGMAN, R. N., PACINI, G., & PORTE, D. (1985) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-60-1-13 · Cited by 353 · see citing works

Neurodegenerative disorders associated with diabetes mellitus

Ristow, M. (2004) · Journal of Molecular Medicine · doi:10.1007/s00109-004-0552-1 · Cited by 350 · see citing works

Insulin resistance reduces arterial prostacyclin synthase and eNOS activities by increasing endothelial fatty acid oxidation

Du, X., Edelstein, D., Obici, S., Higham, N., Zou, M., & Brownlee, M. (2006) · Journal of Clinical Investigation · doi:10.1172/jci23354 · Cited by 344 · see citing works

Spontaneous diabetes mellitus in transgenic mice expressing human islet amyloid polypeptide.

Janson, J., Soeller, W. C., Roche, P. C., Nelson, R. T., Torchia, A. J., Kreutter, D. K., & Butler, P. C. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.14.7283 · Cited by 343 · see citing works

The Roles of Cyclin-dependent Kinase 5 and Glycogen Synthase Kinase 3 in Tau Hyperphosphorylation

Plattner, F., Angelo, M., & Giese, K. P. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603469200 · Cited by 340 · see citing works

Trehalose differentially inhibits aggregation and neurotoxicity of beta-amyloid 40 and 42

LIU, R., Barkhordarian, H., Emadi, S., PARK, C., & Sierks, M. R. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.02.003 · Cited by 340 · see citing works

Role for neuronal insulin resistance in neurodegenerative diseases

Schubert, M., Gautam, D., Surjo, D., Ueki, K., Baudler, S., Schubert, D., Kondo, T., Alber, J., Galldiks, N., Kustermann, E., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308724101 · Cited by 339 · see citing works

Altered glycan-dependent signaling induces insulin resistance and hyperleptinemia

McClain, D. A., Lubas, W. A., Cooksey, R. C., Hazel, M., Parker, G. J., Love, D. C., & Hanover, J. A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.152346899 · Cited by 337 · see citing works

Analysis of microtubule-associated protein tau glycation in paired helical filaments.

Ledesma, M. D., Bonay, P., Colaço, C., & Avila, J. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31849-5 · Cited by 333 · cited 1× · see citing works

Reduced Hippocampal Insulin-Degrading Enzyme in Late-Onset Alzheimer's Disease Is Associated with the Apolipoprotein E-ε4 Allele

Cook, D. G., Leverenz, J. B., McMillan, P. J., Kulstad, J. J., Ericksen, S., Roth, R. A., Schellenberg, G. D., Jin, L., Kovacina, K. S., & Craft, S. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63822-9 · Cited by 329 · see citing works

Molecular indices of oxidative stress and mitochondrial dysfunction occur early and often progress with severity of Alzheimer's disease

de la Monte, S. M., & Wands, J. R. (2006) · Journal of Alzheimer s Disease · doi:10.3233/jad-2006-9209 · Cited by 318 · see citing works

Does insulin dysfunction play a role in Alzheimer's disease?

Gasparini, L. (2002) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(02)02037-0 · Cited by 314 · see citing works

Modulation of memory by insulin and glucose: Neuropsychological observations in Alzheimer’s disease

Watson, G. S., & Craft, S. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.02.048 · Cited by 307 · see citing works

Protein fibrils in nature can enhance amyloid protein A amyloidosis in mice: Cross-seeding as a disease mechanism

Lundmark, K., Westermark, G. T., Olsén, A., & Westermark, P. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501814102 · Cited by 305 · see citing works

Alzheimer's disease – synergistic effects of glucose deficit, oxidative stress and advanced glycation endproducts

Münch, G. W., Schinzel, R., Loske, C., Wong, A. O., Durany, N., Li, J. J., Vlassara, H., Smith, M. A., Perry, G. L., & Riederer, P. F. (1998) · Journal of Neural Transmission · doi:10.1007/s007020050069 · Cited by 302 · see citing works

Neuron-mediated generation of regulatory T cells from encephalitogenic T cells suppresses EAE

Liu, Y., Teige, I., Birnir, B., & Issazadeh‐Navikas, S. (2006) · Nature Medicine · doi:10.1038/nm1402 · Cited by 302 · see citing works

The influence of amyloid deposits on the islet volume in maturity onset diabetes mellitus

Westermark, P., & Wilander, E. (1978) · Diabetologia · doi:10.1007/bf01219652 · Cited by 291 · see citing works

Therapy insight, type 2 diabetes mellitus and the risk of late-onset Alzheimer's disease

Haan, M. N. (2006) · Nature Clinical Practice Neurology · doi:10.1038/ncpneuro0124 · Cited by 284 · see citing works

Islet amyloid formation associated with hyperglycemia in transgenic mice with pancreatic beta cell expression of human islet amyloid polypeptide.

Verchere, C. B., D'Alessio, D. A., Palmiter, R. D., Weir, G. C., Bonner-Weir, S., Baskin, D. G., & Kahn, S. E. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.8.3492 · Cited by 278 · see citing works

In vitro autoradiographic localization of amylin binding sites in rat brain

Sexton, P. M., Paxinos, G., Kenney, M. A., Wookey, P. J., & Beaumont, K. C. (1994) · Neuroscience · doi:10.1016/0306-4522(94)90388-3 · Cited by 277 · see citing works

Potential roles of insulin and IGF-1 in Alzheimer's disease

Gasparini, L., & Xu, H. (2003) · Trends in Neurosciences · doi:10.1016/s0166-2236(03)00163-2 · Cited by 275 · see citing works

Increased risk of Alzheimer's disease in Type II diabetes: insulin resistance of the brain or insulin-induced amyloid pathology?

Biessels, G. J., & Kappelle, L. J. (2005) · Biochemical Society Transactions · doi:10.1042/bst0331041 · Cited by 266 · see citing works

Insulin increases CSF Aβ42 levels in normal older adults

Watson, G. S., Peskind, E. R., Asthana, S., Purganan, K., Wait, C., Chapman, D., Schwartz, M. W., Plymate, S. R., & Craft, S. (2003) · Neurology · doi:10.1212/01.wnl.0000065916.25128.25 · Cited by 265 · see citing works

The role of insulin and insulin-like growth factor I in the molecular and cellular mechanisms underlying the pathology of Alzheimer's disease

Carro, E., & Torres‐Alemán, I. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.02.050 · Cited by 262 · see citing works

Intracerebroventricular injection of streptozotocin in rats produces both oxidative stress in the brain and cognitive impairment

Sharma, M., & Gupta, Y. K. (2001) · Life Sciences · doi:10.1016/s0024-3205(00)01005-5 · Cited by 260 · see citing works

Angiogenesis induced by advanced glycation end products and its prevention by cerivastatin

Okamoto, T., Yamagishi, S., Inagaki, Y., Amano, S., Koga, K., Abe, R., Takeuchi, M., Ohno, S., Yoshimura, A., & Makita, Z. (2002) · The FASEB Journal · doi:10.1096/fj.02-0030fje · Cited by 258 · see citing works

Immunohistochemical distribution of the receptor for advanced glycation end products in neurons and astrocytes in Alzheimer’s disease

Sasaki, N., Toki, S., Chowei, H., Saito, T., Nakano, N., Hayashi, Y., Takeuchi, M., & Makita, Z. (2001) · Brain Research · doi:10.1016/s0006-8993(00)03075-4 · Cited by 253 · see citing works

Increased glycogen synthase kinase-3 activity in diabetes- and obesity-prone C57BL/6J mice.

Eldar-Finkelman, H., Schreyer, S. A., Shinohara, M. M., LeBoeuf, R. C., & Krebs, E. G. (1999) · Diabetes · doi:10.2337/diabetes.48.8.1662 · Cited by 253 · see citing works

Lesion of the Area Postrema/Nucleus of the Solitary Tract (AP/NTS) Attenuates the Anorectic Effects of Amylin and Calcitonin Gene-Related Peptide (CGRP) in Rats

Lutz, T. A., Senn, M., Althaus, J., Prete, E. D., Ehrensperger, F., & Scharrer, E. (1998) · Peptides · doi:10.1016/s0196-9781(97)00292-1 · Cited by 240 · see citing works

Leptin Induces Insulin-like Signaling That Antagonizes cAMP Elevation by Glucagon in Hepatocytes

Zhao, A. Z., Shinohara, M. M., Huang, D., Shimizu, M., Eldar-Finkelman, H., Krebs, E. G., Beavo, J. A., & Bornfeldt, K. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.15.11348 · Cited by 238 · see citing works

Expression of transforming growth factor-β1 during diabetic renal hypertrophy

Shankland, S. J., Scholey, J. W., Ly, H., & Thai, K. (1994) · Kidney International · doi:10.1038/ki.1994.291 · Cited by 233 · see citing works

Transforming growth factor-β1 is in plaques in Alzheimer and Down pathologies

van der Wal, E. A., Gómez‐Pinilla, F., & Cotman, C. W. (1993) · Neuroreport · doi:10.1097/00001756-199301000-00018 · Cited by 230 · see citing works

Transforming Growth Factor-β 1 Prevents Glutamate Neurotoxicity in Rat Neocortical Cultures and Protects Mouse Neocortex from Ischemic Injury in vivo

Prehn, J. H. M., Backhauß, C., & Krieglstein, J. (1993) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1993.67 · Cited by 226 · see citing works

Learning and hippocampal synaptic plasticity in streptozotocin-diabetic rats: interaction of diabetes and ageing

Kamal, A., Biessels, G. J., Duis, S., & Gispen, W. H. (2000) · Diabetologia · doi:10.1007/s001250051335 · Cited by 223 · see citing works

Regulation of neuronal Bcl2 protein expression and calcium homeostasis by transforming growth factor type beta confers wide-ranging protection on rat hippocampal neurons.

Prehn, J. H. M., Bindokas, V. P., Marcuccilli, C. J., et al. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.26.12599 · Cited by 223 · see citing works

Alzheimer‐like changes in protein kinase B and glycogen synthase kinase‐3 in rat frontal cortex and hippocampus after damage to the insulin signalling pathway

Šalković‐Petrišić, M., Tribl, F., Schmidt, M., Hoyer, S., & Riederer, P. F. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03637.x · Cited by 223 · see citing works

2-(8-Hydroxy-6-Methoxy-1-Oxo-1H-2-Benzopyran-3-yl) Propionic Acid, an Inhibitor of Angiogenesis, Ameliorates Renal Alterations in Obese Type 2 Diabetic Mice

Ichinose, K., Maeshima, Y., Yamamoto, Y., Kinomura, M., Hirokoshi, K., Kitayama, H., Takazawa, Y., Sugiyama, H., Yamasaki, Y., Agata, N., et al. (2006) · Diabetes · doi:10.2337/diabetes · Cited by 217 · see citing works

Suppression of transforming growth factor beta and vascular endothelial growth factor in diabetic nephropathy in rats by a novel advanced glycation end product inhibitor, OPB-9195

Tsuchida, K., Makita, Z., Yamagishi, S., Atsumi, T., Miyoshi, H., OBARA, S., Ishida, M., Ishikawa, S., YASUMURA, K., & Koike, T. (1999) · Diabetologia · doi:10.1007/s001250051198 · Cited by 214 · see citing works

Transforming growth factor β gene maps to human chromosome 19 long arm and to mouse chromosome 7

Fujii, D. M., Brissenden, J. E., Derynck, R., et al. (1986) · Somatic Cell and Molecular Genetics · doi:10.1007/bf01570787 · Cited by 213 · see citing works

Insulin and insulin-like growth factor receptors in the nervous system

Adamo, M. L., Raizada, M. K., & LeRoith, D. (1989) · Molecular Neurobiology · doi:10.1007/bf02935589 · Cited by 212 · see citing works

Advanced Glycation End Products-Induced Apoptosis and Overexpression of Vascular Endothelial Growth Factor in Bovine Retinal Pericytes

Yamagishi, S., Amano, S., Inagaki, Y., Okamoto, T., Koga, K., Sasaki, N., Yamamoto, H., Takeuchi, M., & Makita, Z. (2002) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.6312 · Cited by 210 · see citing works

Insulin and Cognitive Function in an Elderly Population: The Rotterdam Study

Stolk, R. P., Breteler, M. M. B., Ott, A., Pols, H. A. P., Lamberts, S. W. J., Grobbee, D. E., & Albert Hofman, D. (1997) · Diabetes Care · doi:10.2337/diacare.20.5.792 · Cited by 208 · see citing works

Expression of transforming growth factor-beta1 and type IV collagen in the renal tubulointerstitium in experimental diabetes: effects of ACE inhibition.

Gilbert, R. E., Cox, A., Wu, L. L., et al. (1998) · Diabetes · doi:10.2337/diabetes.47.3.414 · Cited by 204 · see citing works

Insulin and insulin receptors in rodent brain

Havrankova, J., Brownstein, M., & Roth, J. (1981) · Diabetologia · doi:10.1007/bf00254492 · Cited by 201 · see citing works

Neurotoxicity of Advanced Glycation End-Products for Cultured Cortical Neurons

Takeuchi, M., Bucala, R., Suzuki, T., Ohkubo, T., Yamazaki, M., Koike, T., Kameda, Y., & Makita, Z. (2000) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/59.12.1094 · Cited by 198 · see citing works

Insulin Effects on Glucose Metabolism, Memory, and Plasma Amyloid Precursor Protein in Alzheimer's Disease Differ According to Apolipoprotein‐E Genotype

Craft, S., Asthana, S., Schellenberg, G. D., Baker, L. D., Cherrier, M. M., Boyt, A., Martins, R. N., Raskind, M. A., Peskind, E. R., & Plymate, S. R. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06371.x · Cited by 191 · see citing works

Insulin-degrading enzyme: embarking on amyloid destruction

Kurochkin, I. V. (2001) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(01)01876-x · Cited by 178 · see citing works

Therapeutic actions of insulin-like growth factor I on APP/PS2 mice with severe brain amyloidosis

Carro, E., Trejo, J. L., Gerber, A., Loetscher, H., Torrado, J. J., Metzger, F., & Torres‐Alemán, I. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.06.015 · Cited by 178 · see citing works

Transforming Growth Factor-βs Are Essential for the Development of Midbrain Dopaminergic NeuronsIn VitroandIn Vivo

Farkas, L. M., Dünker, N., Roussa, E., Unsicker, K., & KRIEGLSTEIN, K. G. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-12-05178.2003 · Cited by 174 · see citing works

Inhibition of Central Amylin Signaling Increases Food Intake and Body Adiposity in Rats

Rushing, P. A., Hagan, M. M., Seeley, R. J., Lutz, T. A., D’Alessio, D. A., Air, E. L., & Woods, S. C. (2001) · Endocrinology · doi:10.1210/endo.142.11.8593 · Cited by 173 · see citing works

Role of Glycogen Synthase Kinase-3 in Cell Fate and Epithelial-Mesenchymal Transitions

Doble, B. W., & Woodgett, J. R. (2007) · Cells Tissues Organs · doi:10.1159/000101306 · Cited by 169 · see citing works

The transcription factor PDX-1 is post-translationally modified by O-linked N-acetylglucosamine and this modification is correlated with its DNA binding activity and insulin secretion in min6 β-cells

Gao, Y., Miyazaki, J., & Hart, G. W. (2003) · Archives of Biochemistry and Biophysics · doi:10.1016/s0003-9861(03)00234-0 · Cited by 169 · see citing works

Molecular connexions between dementia and diabetes

Cole, A. R., Astell, A. J., Green, C., & Sutherland, C. D. (2007) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2007.04.004 · Cited by 161 · see citing works

A Disturbance in the Neuronal Insulin Receptor Signal Transduction in Sporadic Alzheimer's Disease

Frölich, L., Blum-Degen, D., Riederer, P. F., & Hoyer, S. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb07839.x · Cited by 160 · see citing works

Association between serum levels of soluble receptor for advanced glycation end products and circulating advanced glycation end products in type 2 diabetes

Tan, K. C. B., Shiu, S. W. M., Chow, W. S., Leng, L., Bucala, R., & Betteridge, D. J. (2006) · Diabetologia · doi:10.1007/s00125-006-0394-1 · Cited by 159 · see citing works

Increased Insulin Secretion and Glucose Tolerance in Mice Lacking Islet Amyloid Polypeptide (Amylin)

Gebre-Medhin, S., Mulder, H., Pekny, M., Westermark, G., Törnell, J., Westermark, P., Sundler, F., Ahrén, B., & Betsholtz, C. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9308 · Cited by 157 · cited 1× · see citing works

O-GlcNAc modification on IRS-1 and Akt2 by PUGNAc inhibits their phosphorylation and induces insulin resistance in rat primary adipocytes

Park, S. Y., Ryu, J., & Lee, W. (2005) · Experimental & Molecular Medicine · doi:10.1038/emm.2005.30 · Cited by 156 · see citing works

β‐Amyloid precursor protein is modified with O‐linked N‐acetylglucosamine

Griffith, L. S., Mathes, M., & Schmitz, B. (1995) · Journal of Neuroscience Research · doi:10.1002/jnr.490410214 · Cited by 154 · see citing works

Transforming growth factor-beta 1 reduces infarct size after experimental cerebral ischemia in a rabbit model.

Gross, C. E., Bednar, M. M., Howard, D. B., et al. (1993) · Stroke · doi:10.1161/01.str.24.4.558 · Cited by 154 · see citing works

Cerebral dysfunction in type 1 diabetes: effects of insulin, vascular risk factors and blood-glucose levels

Brands, A. M. A., Kessels, R. P. C., de Haan, E. H. F., Kappelle, L. J., & Biessels, G. J. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.02.053 · Cited by 150 · see citing works

Loss of insulin receptor immunoreactivity from the substantia nigra pars compacta neurons in Parkinson's disease

Moroo, I., Yamada, T., Makino, H., Tooyama, I., McGeer, P., Mcgeer, E., & Hirayama, K. (1994) · Acta Neuropathologica · doi:10.1007/bf00313602 · Cited by 149 · see citing works

Solution Structure of Residues 1-28 of the Amyloid .beta.-Peptide

Talafous, J., Marcinowski, K. J., Klopman, G., & Zagorski, M. G. (1994) · Biochemistry · doi:10.1021/bi00191a006 · Cited by 149 · see citing works

Altered expression of transforming growth factor-beta in Alzheimer's disease

Flanders, K. C., Lippa, C. F., Smith, T. W., Pollen, D. A., & Sporn, M. B. (1995) · Neurology · doi:10.1212/wnl.45.8.1561 · Cited by 147 · see citing works

Local action of the diabetogenic drug, streptozotocin, on glucose and energy metabolism in rat brain cortex

Nitsch, R. M., & Hoyer, S. (1991) · Neuroscience Letters · doi:10.1016/0304-3940(91)90260-z · Cited by 146 · see citing works

N-terminal Cleavage of GSK-3 by Calpain

Goñi‐Oliver, P., Lucas, J. J., Avila, J., & Hernández, F. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702793200 · Cited by 146 · see citing works

Peripheral Hyperinsulinemia Promotes Tau Phosphorylation In Vivo

Freude, S., Plum, L., Schnitker, J., Leeser, U., Udelhoven, M., Krone, W., Brüning, J. C., & Schubert, M. (2005) · Diabetes · doi:10.2337/diabetes.54.12.3343 · Cited by 144 · see citing works

Role of islet amyloid in type 2 diabetes mellitus

Höppener, J. W. M., & Lips, C. J. M. (2006) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2005.12.009 · Cited by 143 · see citing works

Tau Therapeutic Strategies for the Treatment of Alzheimers Disease

Churcher, I. (2006) · Current Topics in Medicinal Chemistry · doi:10.2174/156802606776743057 · Cited by 142 · see citing works

Inhibition of Cyclin-dependent Kinase 5 Activity Protects Pancreatic Beta Cells from Glucotoxicity

Ubeda, M., Rukstalis, J. M., & Habener, J. F. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m604690200 · Cited by 138 · see citing works

Role of transforming growth factor-β in the progression of heart failure

Lim, H., & Zhu, Y. Z. (2006) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-006-6085-8 · Cited by 138 · see citing works

Recombinant O-GlcNAc transferase isoforms: identification of O-GlcNAcase, yes tyrosine kinase, and tau as isoform-specific substrates

Lazarus, B. D., Love, D. C., & Hanover, J. A. (2006) · Glycobiology · doi:10.1093/glycob/cwj078 · Cited by 137 · see citing works

Glucose Mediates the Translocation of NeuroD1 by O-Linked Glycosylation

Andrali, S. S., Qian, Q., & Özcan, S. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m701762200 · Cited by 136 · see citing works

TGF-beta1 somatic gene therapy prevents autoimmune disease in nonobese diabetic mice.

Piccirillo, C. A., Chang, Y., & Prud’homme, G. J. (1998) · PubMed · Cited by 134 · see citing works

Toxic Advanced Glycation End Products (TAGE) Theory in Alzheimer’s Disease

Sato, T., Shimogaito, N., Wu, X., Kikuchi, S., Yamagishi, S., & Takeuchi, M. (2006) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317506289277 · Cited by 133 · see citing works

Statins Cause Intracellular Accumulation of Amyloid Precursor Protein, β-Secretase-cleaved Fragments, and Amyloid β-Peptide via an Isoprenoid-dependent Mechanism

Cole, S. L., Grudzien, A., Manhart, I. O., Kelly, B. L., Oakley, H. D., & Vassar, R. J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413895200 · Cited by 132 · see citing works

Elevated Plasma Levels of Transforming Growth Factor-β1 in NIDDM

Pfeiffer, A. F. H., Middelberg-Bisping, K., Drewes, C., & Schatz, H. (1996) · Diabetes Care · doi:10.2337/diacare.19.10.1113 · Cited by 126 · see citing works

Alzheimer 100 – highlights in the history of Alzheimer research

Jellinger, K. A. (2006) · Journal of Neural Transmission · doi:10.1007/s00702-006-0578-3 · Cited by 124 · see citing works

The Role of CDK5/P25 Formation/Inhibition in Neurodegeneration

Camins, A., Verdaguer, E., Folch, J., Canudas, A. M., & Pallàs, M. (2006) · Drug News & Perspectives · doi:10.1358/dnp.2006.19.8.1043961 · Cited by 124 · see citing works

Insulin-like growth factor-1 and insulin mediate transient site-selective increases in tau phosphorylation in primary cortical neurons

Lesort, M. J., & Johnson, G. V. W. (2000) · Neuroscience · doi:10.1016/s0306-4522(00)00200-1 · Cited by 121 · see citing works

Oral tolerance induced by continuous feeding: enhanced up-regulation of transforming growth factor-β/interleukin-10 and suppression of experimental autoimmune encephalomyelitis

Faria, A. M. C., Maron, R., Ficker, S. M., Slavin, A., Spahn, T. W., & Weiner, H. L. (2003) · Journal of Autoimmunity · doi:10.1016/s0896-8411(02)00112-9 · Cited by 120 · see citing works

Disease modifying therapy for AD?¹

Golde, T. E. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04211.x · Cited by 117 · see citing works

TGF-β1 Somatic Gene Therapy Prevents Autoimmune Disease in Nonobese Diabetic Mice

Piccirillo, C. A., Chang, Y., & Prud’homme, G. J. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.8.3950 · Cited by 117 · see citing works

TAGE (toxic AGEs) hypothesis in various chronic diseases

Takeuchi, M., & Yamagishi, S. (2004) · Medical Hypotheses · doi:10.1016/j.mehy.2004.02.042 · Cited by 116 · see citing works

Concurrent alterations of O‐GlcNAcylation and phosphorylation of tau in mouse brains during fasting

Li, X., Fen, L., Wang, J., & Gong, C. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.04735.x · Cited by 116 · see citing works

Islet amyloid polypeptide: Identification and chromosomal localization of the human gene

Mosselman, S., Höppener, J. W. M., Zandberg, J., van Mansfeld, A. D. M., van Kessel, A. H. M. G., Lips, C. J. M., & Jansz, H. S. (1988) · FEBS Letters · doi:10.1016/0014-5793(88)80922-0 · Cited by 115 · see citing works

Role of advanced glycation end products (AGEs) and their receptor (RAGE) in the pathogenesis of diabetic microangiopathy.

Yamagishi, S., Takeuchi, M., Inagaki, Y., Nakamura, K., & Imaizumi, T. (2003) · PubMed · Cited by 114 · see citing works

Therapy Insight: the impact of type 1 diabetes on brain development and function

NORTHAM, E. A., Rankins, D., & Cameron, F. J. (2006) · Nature Clinical Practice Neurology · doi:10.1038/ncpneuro0097 · Cited by 113 · see citing works

Association of Inflammation Markers with Impaired Insulin Sensitivity and Coagulative Activation in Obese Healthy Women

Romano, M., Guagnano, M. T., Pacini, G., Vigneri, S., Falco, A., Marinopiccoli, M., Manigrasso, M. R., Basili, S., & Davı̀, G. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030508 · Cited by 113 · see citing works

Neuronal rescue with transforming growth factor-β1 after hypoxic-ischaemic brain injury

McNeill, H., Williams, C., Guan, J., Dragunow, M., Lawlor, P. A., Sirimanne, E. S., Nikolics, K., & Gluckman, P. (1994) · Neuroreport · doi:10.1097/00001756-199404000-00012 · Cited by 111 · see citing works

Hepatic phosphotyrosine phosphatase activity and its alterations in diabetic rats.

Meyerovitch, J., Backer, J., & Kahn, C. R. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114261 · Cited by 104 · see citing works

Glycosylation Sites Flank Phosphorylation Sites on Synapsin I

Cole, R. N., & Hart, G. W. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0730418.x · Cited by 102 · see citing works

Contribution of advanced glycosylation to the amyloidogenicity of islet amyloid polypeptide

Kapurniotu, A., Bernhagen, J., Greenfield, N. J., et al. (1998) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1998.2510208.x · Cited by 102 · see citing works

Possible Causes of Alzheimer's Disease: Amyloid Fragments, Free Radicals, and Calcium Homeostasis

Hölscher, C. (1998) · Neurobiology of Disease · doi:10.1006/nbdi.1998.0193 · Cited by 102 · see citing works

Increased cortical atrophy in patients with Alzheimer's disease and type 2 diabetes mellitus

Biessels, G. J. (2005) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2005.069583 · Cited by 100 · see citing works

The potential role of tau protein O-glycosylation in Alzheimer's disease

Robertson, L. A., Moya, K. L., & Breen, K. C. (2004) · Journal of Alzheimer s Disease · doi:10.3233/jad-2004-6505 · Cited by 99 · see citing works

Amylin inhibits bone resorption by a direct effect on the motility of rat osteoclasts

Alam, A., Moonga, B., Bevis, P., Huang, C., & Zaidi, M. (1993) · Experimental Physiology · doi:10.1113/expphysiol.1993.sp003679 · Cited by 99 · see citing works

Alois Alzheimer and Alzheimer's disease: a centennial perspective

Small, D. H., & Cappai, R. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04212.x · Cited by 97 · see citing works

Effects of OPB‐9195, anti‐glycation agent, on experimental diabetic neuropathy

Wada, R., Nishizawa, Y., Yagihashi, N., Takeuchi, M., Ishikawa, Y., YASUMURA, K., Nakano, M., & Yagihashi, S. (2001) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2001.00826.x · Cited by 94 · see citing works

Chromosomal mapping of genes for transforming growth factors beta 2 and beta 3 in man and mouse: dispersion of TGF-beta gene family.

Barton, D. E., Be, F., Du, J., et al. (1988) · PubMed · Cited by 93 · see citing works

The glucagon-like peptides: a new genre in therapeutic targets for intervention in Alzheimer's disease

Perry, T., & Greig, N. H. (2002) · Journal of Alzheimer s Disease · doi:10.3233/jad-2002-4605 · Cited by 91 · see citing works

Long-Term Diabetogenic Effect of Streptozotocin in Rats

Ar'Rajab, A., & Åhrén, B. (1993) · Pancreas · doi:10.1097/00006676-199301000-00011 · Cited by 89 · see citing works

Reduction of O-LinkedN-Acetylglucosamine-Modified Assembly Protein-3 in Alzheimer’s Disease

Yao, P. J., & Coleman, P. D. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-07-02399.1998 · Cited by 85 · see citing works

Targeting Amyloid‐Degrading Enzymes as Therapeutic Strategies in Neurodegeneration

Turner, A. J., Fisk, L., & Nalivaeva, N. N. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1332.001 · Cited by 84 · see citing works

Development of Beta-Amyloid-induced Neurodegeneration in Alzheimer's Disease and Novel Neuroprotective Strategies

Hölscher, C. (2005) · Reviews in the Neurosciences · doi:10.1515/revneuro.2005.16.3.181 · Cited by 82 · see citing works

Anti-amyloidogenic therapies: strategies for prevention and treatment of Alzheimer’s disease

Hamaguchi, T., Ono, K., & Yamada, M. (2006) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5599-9 · Cited by 82 · see citing works

Differential modulation of plasma β-amyloid by insulin in patients with Alzheimer disease

Kulstad, J. J., Green, P. S., Cook, D. G., Watson, G. S., Reger, M. A., Baker, L. D., Plymate, S. R., Asthana, S., Rhoads, K., Mehta, P. D., et al. (2006) · Neurology · doi:10.1212/01.wnl.0000216274.58185.09 · Cited by 82 · see citing works

Abrogation of autoimmune diabetes in nonobese diabetic mice and protection against effector lymphocytes by transgenic paracrine TGF-beta1.

Moritani, M., Yoshimoto, K., Wong, F. S., et al. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2992 · Cited by 81 · see citing works

Cerebrospinal Fluid Levels of -Secretase--Cleaved Soluble Amyloid Precursor Protein Mirror Cognition in a Swedish Family With Alzheimer Disease and a Gene Mutation

Almkvist, O., Basun, H., Wagner, S. L., et al. (1997) · Archives of Neurology · doi:10.1001/archneur.1997.00550170111022 · Cited by 80 · see citing works

Demonstrated brain insulin resistance in Alzheimer’s disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline

Talbot, K., Wang, H.-Y., Kazi, H., Han, L.-Y., Bakshi, K. P., Stucky, A., Fuino, R. L., Kawaguchi, K. R., Samoyedny, A. J., Wilson, R. S., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59903 · Cited by 1,871 · see citing works

How does diabetes accelerate Alzheimer disease pathology?

Sims-Robinson, C., Kim, B., Rosko, A., & Feldman, E. L. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.130 · Cited by 492 · see citing works

Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson’s, Huntington’s, Alzheimer’s, prions, bactericides, chemical toxicology and others as examples

Kell, D. B. (2010) · Archives of Toxicology · doi:10.1007/s00204-010-0577-x · Cited by 361 · see citing works

Diabetes mellitus and Alzheimer's disease: shared pathology and treatment?

Akter, K., Lanza, E. A., Martin, S. A., Myronyuk, N., Rua, M., & Raffa, R. B. (2011) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2010.03830.x · Cited by 352 · see citing works

Benefits in Cognitive Function, Blood Pressure, and Insulin Resistance Through Cocoa Flavanol Consumption in Elderly Subjects With Mild Cognitive Impairment: The Cocoa, Cognition, and Aging (CoCoA) Study

Desideri, G., Kwik-Uribe, C., Grassi, D., Necozione, S., Ghiadoni, L., Mastroiacovo, D., Raffaele, A., Ferri, L., Bocale, R., Lechiara, M. C., et al. (2012) · Hypertension · doi:10.1161/hypertensionaha.112.193060 · Cited by 311 · see citing works

Pleiotropic Effects of GLP-1 and Analogs on Cell Signaling, Metabolism, and Function

Rowlands, J., Heng, J., Newsholme, P., & Carlessi, R. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00672 · Cited by 302 · see citing works

The role of G protein-coupled receptors in the pathology of Alzheimer's disease

Thathiah, A., & De Strooper, B. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn2977 · Cited by 288 · see citing works

Cognitive dysfunction in older adults with diabetes: what a clinician needs to know

Munshi, M. N. (2017) · Diabetes Care · doi:10.2337/dc16-1229 · Cited by 255 · see citing works

Insulin/IGF-like signalling, the central nervous system and aging

Broughton, S., & Partridge, L. (2009) · Biochemical Journal · doi:10.1042/bj20082102 · Cited by 228 · see citing works

Receptors for the incretin glucagon-like peptide-1 are expressed on neurons in the central nervous system

Hamilton, A., & Hölscher, C. (2009) · NeuroReport · doi:10.1097/wnr.0b013e32832fbf14 · Cited by 227 · see citing works

Insulin-resistant brain state: The culprit in sporadic Alzheimer's disease?

Correia, S. C., Santos, R. X., Perry, G., Zhu, X., Moreira, P. I., & Smith, M. A. (2011) · Ageing Research Reviews · doi:10.1016/j.arr.2011.01.001 · Cited by 212 · see citing works

Glucagon-like peptide-1 analogues enhance synaptic plasticity in the brain: A link between diabetes and Alzheimer's disease

McClean, P. L., Gault, V. A., Harriott, P., & Hölscher, C. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.12.023 · Cited by 193 · see citing works

Diabetes, Sarcopenia, and Frailty

Morley, J. E. (2008) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2008.03.004 · Cited by 186 · see citing works

Inflammation and insulin/IGF-1 resistance as the possible link between obesity and neurodegeneration

Spielman, L. J., Little, J. P., & Klegeris, A. (2014) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2014.06.004 · Cited by 182 · see citing works

GSK3: a key target for the development of novel treatments for type 2 diabetes mellitus and Alzheimer disease

Gao, C., Hölscher, C., Liu, Y., & Li, L. (2012) · revneuro · doi:10.1515/rns.2011.061 · Cited by 164 · see citing works

Metabolic Risk Factors of Sporadic Alzheimer's Disease: Implications in the Pathology, Pathogenesis and Treatment

Chakrabarti, S., Kumar Khemka, V., Banerjee, A., Chatterjee, G., Ganguly, A., & Biswas, A. (2015) · Aging and disease · doi:10.14336/ad.2014.002 · Cited by 134 · see citing works

Val8-glucagon-like peptide-1 protects against Aβ1–40-induced impairment of hippocampal late-phase long-term potentiation and spatial learning in rats

Wang, X. H., Li, L., Hölscher, C., Pan, Y. F., Chen, X. R., & Qi, J. S. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.08.028 · Cited by 99 · see citing works

Potential benefits of mindfulness-based interventions in mild cognitive impairment and Alzheimer’s disease: an interdisciplinary perspective.

Larouche, E., Hudon, C., & Goulet, S. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.05.058 · Cited by 93 · see citing works

Curcumin ameliorates impaired insulin/IGF signalling and memory deficit in a streptozotocin-treated rat model

Isik, A. T., Celik, T., Ulusoy, G., Ongoru, O., Elibol, B., Doruk, H., Bozoglu, E., Kayir, H., Mas, M. R., & Akman, S. (2009) · AGE · doi:10.1007/s11357-008-9078-8 · Cited by 76 · see citing works

The Role of GLP-1 in Neuronal Activity and Neurodegeneration

Hölscher, C. (2010) · Vitamins & Hormones · doi:10.1016/b978-0-12-381517-0.00013-8 · Cited by 74 · see citing works

Geniposide Attenuates Insulin-Deficiency-Induced Acceleration of β-amyloidosis in an APP/PS1 Transgenic Model of Alzheimer's Disease

Zhang, Y., Yin, F., Liu, J., Liu, Z., Guo, L., Xia, Z., & Zidichouski, J. (2015) · Neurochemistry International · doi:10.1016/j.neuint.2015.04.002 · Cited by 45 · see citing works

Insulin Receptor Expression and Activity in the Brains of Nondiabetic Sporadic Alzheimer’s Disease Cases

Ho, L., Yemul, S., Knable, L., Katsel, P., Zhao, R., Haroutunian, V., & Pasinetti, G. M. (2012) · International Journal of Alzheimer's Disease · doi:10.1155/2012/321280 · Cited by 21 · see citing works

Predictionof Anti-Diabetic Drugs as Dual Inhibitors Against Acetylcholinesterase and Beta-Secretase: A Neuroinformatics Study

Shaikh, S., Rizvi, S. M., Suhail, T., Shakil, S., Abuzenadah, A., Anis, R., Naaz, D., Dallol, A., Haneef, M., Ahmad, A., et al. (2016) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527315666161003125752 · Cited by 10 · see citing works

Disease-associated protein seeding suggests a dissociation between misfolded protein accumulation and neurodegeneration in prion disease

Alibhai, J. D., Diack, A. B., & Manson, J. C. (2017) · Prion · doi:10.1080/19336896.2017.1378289 · Cited by 5 · see citing works

Nature of Tau-Associated Neurodegeneration and the Molecular Mechanisms

Yang, Y., & Wang, J. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-170788 · Cited by 46 · see citing works

A Possible Neurodegeneration Mechanism Triggered by Diabetes

Farhadi, A., Vosough, M., Zhang, J., Tahamtani, Y., & Shahpasand, K. (2019) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2019.07.012 · Cited by 31 · see citing works

Temperature-Sensitive Paralytic Mutants Are Enriched For Those Causing Neurodegeneration in Drosophila

Palladino, M. J., Hadley, T. J., & Ganetzky, B. (2002) · Genetics · doi:10.1093/genetics/161.3.1197 · Cited by 98 · see citing works

Reactive oxygen species-mediated neurodegeneration is independent of the ryanodine receptor in Caernorhabditis elegans.

Young, L. E. A., & Williams, D. C. (2015) · PubMed · Cited by 3 · see citing works